BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 20443735)

  • 1. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis.
    Wada T; Kurokawa T; Toma T; Shibata F; Tone Y; Hashida Y; Kaya H; Yoshida T; Yachie A
    Eur J Haematol; 2007 Jul; 79(1):72-5. PubMed ID: 17532761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.
    Wada T; Sakakibara Y; Nishimura R; Toma T; Ueno Y; Horita S; Tanaka T; Nishi M; Kato K; Yasumi T; Ohara O; Yachie A
    Hum Immunol; 2013 Dec; 74(12):1579-85. PubMed ID: 24051121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.
    Lin MT; Chang HM; Huang CJ; Chen WL; Lin CY; Lin CY; Chuang SS
    J Clin Pathol; 2007 Jan; 60(1):101-3. PubMed ID: 17213357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of Epstein-Barr virus-infected cells by flow cytometer permits early diagnosis and evaluation of disease progression in EBV-associated hemophagocytic lymphohistiocytosis].
    Fukuda M; Nishimura R; Araki R; Kuroda R; Mase S; Nakagawa Y; Tone Y; Maeba H; Wada T; Kasahara Y; Yachie A
    Rinsho Ketsueki; 2012 Mar; 53(3):337-41. PubMed ID: 22499051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis.
    Ito Y; Kawamura Y; Iwata S; Kawada J; Yoshikawa T; Kimura H
    Pediatr Blood Cancer; 2013 Feb; 60(2):326-8. PubMed ID: 22961815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
    Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
    Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
    Chuang HC; Lay JD; Hsieh WC; Su IJ
    Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic difficulties of the hemophagocytic lymphohistiocytosis (HLH) associated with the Epstein-Barr virus.
    Gonzalo DH; Rodriguez G; Marcilla D
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):206-7. PubMed ID: 17356405
    [No Abstract]   [Full Text] [Related]  

  • 11. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
    Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two young adult cases of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis with monoclonal proliferation of virus-infected cells within a short period after primary infection].
    Idutsu K; Abe Y; Matsushima T; Sada E; Ohtsuka R; Kiyasu J; Shiratsuchi M; Kotoh K; Nishimura J; Ohga S; Takayanagi R
    Rinsho Ketsueki; 2008 Nov; 49(11):1541-7. PubMed ID: 19047785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis.
    Matsuda K; Nakazawa Y; Yanagisawa R; Honda T; Ishii E; Koike K
    Clin Chim Acta; 2011 Aug; 412(17-18):1554-8. PubMed ID: 21570959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis.
    Park MS; Yoo IY; Kim HJ; Kim SH; Kim SJ; Cho D
    Ann Lab Med; 2019 Sep; 39(5):430-437. PubMed ID: 31037861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
    Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
    Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kawada J; Kimura H; Shibata Y; Hara S; Hoshino Y; Kojima S; Nishikawa K; Morishima T
    J Med Virol; 2006 Mar; 78(3):400-7. PubMed ID: 16419109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
    Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.